Dr. Campbell Le Heron
Dr. Campbell Le Heron is a Christchurch-based dementia specialist and principal investigator in New Zealand for the DIAN-TU 001 clinical trial, which explores new generation drugs aimed at slowing the progression of Alzheimer’s disease, particularly in patients with the rare PSEN1 gene mutation.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Dr. Campbell Le Heron is a dementia specialist who acknowledges the challenges of new Alzheimer’s treatments.
6